25
Participants
Start Date
October 31, 2011
Primary Completion Date
August 31, 2013
Study Completion Date
August 31, 2013
preoperative induction chemotherapy in combination with bevacizumab followed by combined radiochemotherapy with capecitabine
Therapy start: Capecitabine 1000mg/ m² bid during 14 days(d1-14), oxaliplatin 130mg/m² and Bevacizumab 7.5mg/kg body weight d1, repetition day 22 and 43 (3 cycles) Radiotherapy: Followed by 5 x 5 days 1.8 Gy after 1 week of concluded 3rd cycle of induction chemotherapy Chemotherapy: Capecitabine 825 mg/m2 bid (on each therapy day of first 4 therapy weeks)
Medical University of Vienna, General Hospital, Vienna
Klinikum Wels-Grieskirchen, Wels
Paracelsus Medical University Salzburg - Oncology, Salzburg
Medical University Innsbruck, Internal Medicine, Innsbruck
State Hospital Feldkirch, Radiotherapy, Feldkirch
Medical University Graz, Oncology, Graz
Hospital BHB St. Veit/Glan, Surgery, Saint Veit A. D. Glan
Hoffmann-La Roche
INDUSTRY
Austrian Breast & Colorectal Cancer Study Group
NETWORK